Sandra horning biography

Dr.
Sandra joined Roche in late 2009 as Senior Vice President, Global Head of Clinical.
Sandra Horning is an author of books for young children, including The Biggest Pumpkin, Chicks!, and The Giant Hug, which has been translated into many.

•

Sandra Horning

Sandra J. Horning, M.D., FACP, FASCO, was appointed Chief Medical Officer and head of Global Product Development of Roche and Genentech in January 2014. She oversees late stage clinical development and co-chairs the Late Stage Portfolio Committee. Sandra joined Roche in late 2009 as senior vice president, global head of clinical oncology and hematology product development. She is an Emerita Professor of Medicine (Oncology and Blood and Bone Marrow Transplantation) at Stanford University School of Medicine where she served as a tenured professor, practicing oncologist and investigator, and held multiple leadership positions including Vice-Chair of the Department of Medicine prior to joining Roche/Genentech.

Sandra has authored 300 peer-reviewed journal articles, book chapters, reviews and editorials, and has served on the editorial boards of multiple peer-reviewed medical journals. She was named a Best Doctor in America consecutively from 1992-2008 and served as Chairman of the Eastern Cooperative Oncology Group lymphoma committee and 2005-6 President of the Ameri

•

Lymphoma Expert and Industry Leader Sandra J. Horning, MD, Pushes the Frontiers of Drug Development and Oncology Research

Due to childhood health issues, Sandra J. Horning, MD, formed an opinion about doctors at a young age: They were good people who helped other people. By her early teens, Dr. Horning began to ponder a career in medicine, which offered the possibility of blending her love of science with a career that would benefit the lives of others. “I grew up in a small town in Iowa called Creston, and physicians were among the most respected citizens in our community. But I also found it interesting that when I went to the clinic, all of the nurses were women and the doctors were men. As a young girl, I wondered why that was so,” Dr. Horning told The ASCO Post.

Dr. Horning had no family members close or distant who worked in the medical field, so it was purely experiential knowledge that drew her into medicine. “I was the first on either side of my family to go to medical school. I think I was 14 years old when I firmly decided that I was going to be a doctor. I was an

•

Sandra Horning (Roche (Group))

Person › Details

Horning, Sandra (Roche 201401â201912 CMO + Head Global Product Development joined 2009 RETIRED 12/19)

Genentech, Inc.. (8/19/19). "Press Release: Retirement of Dr. Sandra Horning & Appointment of Dr. Levi Garraway to Chief Medical Officer, Roche and Genentech". South San Francisco, CA.

Dr. Sandra Horning, Chief Medical Officer and Head of Global Product Development will retire on December 31, 2019. During her decade-long tenure with Roche and Genentech, Dr. Horning brought 15 new medicines to patients and tackled some of the worldâs toughest diseases including cancer, multiple sclerosis, influenza and blindness. We thank her for her incredible contributions to medicine and to the employees at our company who have been inspired and motivated by her commitment to science and patients.

Dr. Levi Garraway, who was most recently Eli Lillyâs Senior Vice President, Oncology Research & Development and Lilly Research Laboratories Novel Target Research, will succeed Dr. Horning as Chief Medical Officer